BioSpace News Archive

Pharm Country

Palatin Receives $4.7 Million of Non-Dilutive Funding

Palatin Technologies, Inc. today announced it has received approximately $4.7 million of non-dilutive funding through the New Jersey’s Technology Business Tax Certificate Transfer Program, more commonly known as the Net Operating Loss (NOL) Program.

January 18, 2023
·
3 min read
Cybin Announces Promising Results from Sponsored Kernel Flow® Feasibility Study Measuring Psychedelic Effects on the Brain

Cybin Announces Promising Results from Sponsored Kernel Flow ® Feasibility Study Measuring Psychedelic Effects on the Brain.

January 18, 2023
·
9 min read
Bio NC

Novan to Present at the Virtual Investor 2023 Companies to Watch Event

Novan, Inc., announced that Paula Brown Stafford, President and Chief Executive Officer of Novan, will present at the Virtual Investor 2023 Companies to Watch Event on Thursday, January 19, 2023 at 12:00 PM ET.

January 18, 2023
·
1 min read
Business

IRADIMED CORPORATION Announces Preliminary Financial Results for Fourth Quarter 2022

IRADIMED CORPORATION (the “Company”) (NASDAQ: IRMD) today announced selected preliminary financial results for the fourth quarter that ended December 31, 2022.

January 18, 2023
·
5 min read
Drug Development

European Commission Grants Orphan Drug Designation for aTyr Pharma’s Efzofitimod for Treatment of SarcoidosisGlobal pivotal Phase 3 EFZO-FIT™ study in pulmonary sarcoidosis launched in Europe

aTyr Pharma, Inc. (Nasdaq: LIFE), a biotherapeutics company engaged in the discovery and development of first-in-class medicines from its proprietary tRNA synthetase platform, today announced that the European Commission (EC) granted orphan drug designation for the company’s lead therapeutic candidate, efzofitimod, for the treatment of sarcoidosis based on the opinion of the European Medicines Agency (EMA) Committee for Orphan Medicinal Products (COMP).

January 18, 2023
·
6 min read
Pharmascience Canada launched (PR)pms-DEFERASIROX (TYPE J), a generic drug indicated in the management of chronic iron

Pharmascience Canada now adds PRpms-DEFERASIROX (TYPE J) to its product catalogue, available in 90 mg and 360 mg tablets.

January 18, 2023
·
1 min read
IceCure Receives Notice of Patent Allowance in Japan for a Novel Cryogenic Pump for its Next-Generation Cryoablation Systems

IceCure Medical Ltd today announced it has received a Notice of Allowance from the Japan Patent Office (the “JPO”) for IceCure’s patent application titled “Cryogen Pump”.

January 18, 2023
·
3 min read
Business

Sensorium Therapeutics Appoints Jeffrey M. Brown as Chief Scientific Officer

Sensorium Therapeutics today announced the appointment of Jeffrey M. Brown, Ph.D., MBA as Chief Scientific Officer.

January 18, 2023
·
3 min read
Biotech Bay

National Comprehensive Cancer Network® Adds Newly Approved REZLIDHIA™ (olutasidenib) to Clinical Practice Guidelines in Oncology for Acute Myeloid Leukemia

Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced that REZLIDHIA™ (olutasidenib) has been added by the National Comprehensive Cancer Network® (NCCN®) to the latest NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) for acute myeloid leukemia (AML).

January 18, 2023
·
10 min read
BioCapital

Novavax Nuvaxovid COVID-19 Vaccine Approved in South Korea as an Adult Booster

Novavax, Inc. today announced that partner SK bioscience has received expanded manufacturing and marketing approval from the Korean Ministry of Food and Drug Safety (KMFDS) for Nuvaxovid™ (NVX-CoV2373) for use as a booster for active immunization to prevent COVID-19 in adults aged 18 and older.

January 18, 2023
·
9 min read